Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
CNY 79.03
(1.18%)
CNY 79.03
(1.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 395.49 Million CNY | 48.68% |
| 2022 | 242.96 Million CNY | 23.06% |
| 2021 | 197.42 Million CNY | 56.93% |
| 2020 | 125.8 Million CNY | 23.32% |
| 2019 | 102.01 Million CNY | 26.36% |
| 2018 | 80.73 Million CNY | 43.65% |
| 2017 | 56.2 Million CNY | 44.02% |
| 2016 | 39.02 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 107.52 Million CNY | -7.89% |
| 2024 Q2 | 119.69 Million CNY | 11.32% |
| 2023 Q1 | 72.46 Million CNY | -13.31% |
| 2023 FY | 361.23 Million CNY | 48.68% |
| 2023 Q4 | 116.73 Million CNY | 8.66% |
| 2023 Q3 | 107.42 Million CNY | 19.51% |
| 2023 Q2 | 89.88 Million CNY | 24.03% |
| 2022 FY | 242.96 Million CNY | 23.06% |
| 2022 Q4 | 83.59 Million CNY | 27.82% |
| 2022 Q3 | 65.4 Million CNY | 28.95% |
| 2022 Q2 | 50.71 Million CNY | 17.28% |
| 2022 Q1 | 43.24 Million CNY | -28.15% |
| 2021 Q1 | 35.59 Million CNY | -26.92% |
| 2021 Q3 | 56.34 Million CNY | 24.39% |
| 2021 Q2 | 45.3 Million CNY | 27.27% |
| 2021 Q4 | 60.18 Million CNY | 6.81% |
| 2021 FY | 197.42 Million CNY | 56.93% |
| 2020 Q3 | 32.48 Million CNY | 35.4% |
| 2020 Q1 | 20.36 Million CNY | 304.68% |
| 2020 FY | 125.8 Million CNY | 23.32% |
| 2020 Q4 | 48.7 Million CNY | 49.93% |
| 2020 Q2 | 23.99 Million CNY | 17.81% |
| 2019 Q4 | -9.94 Million CNY | -135.1% |
| 2019 FY | 102.01 Million CNY | 26.36% |
| 2019 Q3 | 28.34 Million CNY | 11.99% |
| 2019 Q2 | 25.31 Million CNY | 50.55% |
| 2019 Q1 | 16.81 Million CNY | 290.59% |
| 2018 Q4 | -8.82 Million CNY | 0.0% |
| 2018 FY | 80.73 Million CNY | 43.65% |
| 2017 FY | 56.2 Million CNY | 44.02% |
| 2016 FY | 39.02 Million CNY | 0.0% |